498
Participants
Start Date
October 2, 2018
Primary Completion Date
December 20, 2019
Study Completion Date
December 27, 2019
Insulin degludec
Participants will receive insulin degludec U100 subcutaneous (s.c.) injection once daily for 36 weeks. Doses will be adjusted according to the fasting self-measured plasma glucose (SMPG) values. Participants earlier treated with one or more allowed oral antidiabetic drug(s) (OAD(s)), should continue their pre-trial OAD(s) treatment throughout the trial.
Insulin glargine
Participants will receive insulin glargine U100 s.c. injection once daily for 36 weeks. Doses will be adjusted according to the fasting SMPG values. Participants earlier treated with one or more allowed OAD(s), should continue their pre-trial OAD(s) treatment throughout the trial.
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Lenasia
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Port Elizabeth
Novo Nordisk Investigational Site, Cape Town
Novo Nordisk Investigational Site, Bloemfontein
Novo Nordisk Investigational Site, New Windsor
Novo Nordisk Investigational Site, Greenville
Novo Nordisk Investigational Site, Statesville
Novo Nordisk Investigational Site, Pelzer
Novo Nordisk Investigational Site, Orlando
Novo Nordisk Investigational Site, Cooper City
Novo Nordisk Investigational Site, Hollywood
Novo Nordisk Investigational Site, Pembroke Pines
Novo Nordisk Investigational Site, Bradenton
Novo Nordisk Investigational Site, New Port Richey
Novo Nordisk Investigational Site, Nashville
Novo Nordisk Investigational Site, Louisville
Novo Nordisk Investigational Site, Lexington
Novo Nordisk Investigational Site, Toledo
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Dakota Dunes
Novo Nordisk Investigational Site, Kalispell
Novo Nordisk Investigational Site, Skokie
Novo Nordisk Investigational Site, Topeka
Novo Nordisk Investigational Site, Kerrville
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Amarillo
Novo Nordisk Investigational Site, Chandler
Novo Nordisk Investigational Site, Tucson
Novo Nordisk Investigational Site, Northridge
Novo Nordisk Investigational Site, Van Nuys
Novo Nordisk Investigational Site, Trnava
Novo Nordisk Investigational Site, Poway
Novo Nordisk Investigational Site, Levice
Novo Nordisk Investigational Site, Lancaster
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Hamden
Novo Nordisk Investigational Site, Boston
Novo Nordisk Investigational Site, Boston
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Calgary
Novo Nordisk Investigational Site, Victoria
Novo Nordisk Investigational Site, Concord
Novo Nordisk Investigational Site, Etobicoke
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Markham
Novo Nordisk Investigational Site, Oakville
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Montreal
Novo Nordisk Investigational Site, Bialystok
Novo Nordisk Investigational Site, Bialystok
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Lublin
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Ponce
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Bytča
Novo Nordisk Investigational Site, Malacky
Novo Nordisk Investigational Site, Nové Mesto nad Váhom
Novo Nordisk Investigational Site, Nové Zámky
Novo Nordisk Investigational Site, Trebišov
Novo Nordisk Investigational Site, Žilina
Novo Nordisk Investigational Site, Pretoria
Lead Sponsor
Novo Nordisk A/S
INDUSTRY